Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, PAYCHEX INC insiders sold a net $4.6M of stock across 122 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Jul 16, 2025.
The trade is 14.0% of the 18,547 shares held after it.
3 other insiders sold within 30 days.
791 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Sr. VP, CFO Schrader Robert L. sold about $299.2K of PAYX on Jul 20, 2026; 3 other insiders sold within 30 days and 791 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jul 16, 2025.
The trade is 76.5% of the 3,420 shares held after it.
3 other insiders sold within 30 days.
791 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, Controller & Treasurer Simmons Christopher C sold about $303.1K of PAYX on Jul 17, 2026; 3 other insiders sold within 30 days and 791 funds added in the latest 13F quarter.
13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Jul 10, 2025.
The trade is 5.6% of the 444,200 shares held after it.
3 other insiders sold within 30 days.
791 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MUCCI MARTIN sold about $2.7M of PAYX on Jul 14, 2026, the largest insider sale at the company since 2025; 3 other insiders sold within 30 days and 791 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jul 10, 2023.
The trade is 5.8% of the 67,364 shares held after it.
3 other insiders sold within 30 days.
791 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director TUCCI JOSEPH M sold about $383.9K of PAYX on Jun 26, 2026; 3 other insiders sold within 30 days and 791 funds added in the latest 13F quarter.
122 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
PAYX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Golisano B Thomas
Filed 2026-10-23
$2.5M
GOLISANO B THOMAS
Filed 2026-10-21
$32.7M
GOLISANO B THOMAS
Filed 2026-10-21
$1.7M
VELLI JOSEPH M
Filed 2026-10-14
$844.1K
Golisano B Thomas
Filed 2026-09-29
$56.2M
PAYX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Brookstone Dividend Stock ETF
$4.8M position · as of 2026-05-31
5.0%
Federated Hermes U.S. Strategic Dividend ETF
$38.9M position · as of 2026-07-31
4.4%
Federated Hermes Strategic Value Dividend Fund
$420.5M position · as of 2026-07-31
4.2%
Federated Hermes Enhanced Income ETF
$2.3M position · as of 2026-07-31
4.1%
Poplar Forest Partners Fund
$14.9M position · as of 2026-06-30
3.9%
Franklin U.S. Dividend Booster Index ETF
$2.8M position · as of 2026-06-30
3.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · John B.Gibson
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$8.8M
$16.4M
$2.9M
+74%
+47%
2023
$7.5M
$8.5M
$2.5M
+29%
+21%
2021
$11.0M
$23.3M
$3.3M
+25%
-7%
2020
$9.6M
$21.1M
$2.6M
+44%
+27%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.6M sold by insiders over 180 days, 791 funds added last quarter, 2 House member(s) bought in 12 months, disclosed weeks after the trade, $93.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.6B
four quarters, 2025-09-01 to 2026-08-31
Revenue, TTM PAYX
FY May 2026
$6.5B
FY May 2025
$5.6B
FY May 2024
$5.3B
FY May 2023
$5.0B
FY May 2022
$4.6B
Aug 2026
$1.6B
May 2026
$1.6B
Feb 2026
$1.8B
Nov 2025
$1.6B
Aug 2025
$1.5B
May 2025
$1.4B
Feb 2025
$1.5B
Nov 2024
$1.3B
At each fiscal year end
Single quarter
Net margin, TTM
+27.4%
net income over revenue, 2025-09-01 to 2026-08-31
Net margin, TTM PAYX
FY May 2026
+27.0%
FY May 2025
+29.7%
FY May 2024
+0.0%
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
+26.4%
May 2026
+26.2%
Feb 2026
+31.0%
Nov 2025
+25.4%
Aug 2025
+24.9%
May 2025
+20.8%
Feb 2025
+34.4%
Nov 2024
+31.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.0B
operating cash flow minus capex, 2025-09-01 to 2026-08-31
Free cash flow, TTM PAYX
FY May 2026
$2.3B
FY May 2025
$1.7B
FY May 2024
$1.7B
FY May 2023
$1.6B
FY May 2022
$1.5B
Aug 2026
$357.4M
May 2026
$515.0M
Feb 2026
$761.5M
Nov 2025
$382.8M
Aug 2025
$662.5M
May 2025
$283.3M
Feb 2025
$667.3M
Nov 2024
$248.0M
At each fiscal year end
Single quarter
Debt to equity
1.23x
long-term 2026-08-31 plus current 2026-05-31; equity 2026-08-31
Debt to equity PAYX
FY May 2026
1.22x
FY May 2025
1.20x
FY May 2024
0.21x
FY May 2023
0.23x
FY May 2022
0.26x
Aug 2026
1.23x
May 2026
1.22x
Feb 2026
1.23x
Nov 2025
1.28x
Aug 2025
1.25x
May 2025
1.20x
Feb 2025
0.20x
Nov 2024
0.21x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.49x
TTM operating cash flow over long-term 2026-08-31 plus current 2026-05-31
Cash flow to debt PAYX
FY May 2026
0.56x
FY May 2025
0.38x
FY May 2024
2.38x
FY May 2023
2.11x
FY May 2022
1.97x
Aug 2026
0.49x
May 2026
0.56x
Feb 2026
0.47x
Nov 2025
0.45x
Aug 2025
0.42x
May 2025
0.38x
Feb 2025
2.18x
Nov 2024
2.12x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+47.1%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on equity PAYX
FY May 2026
+44.8%
FY May 2025
+41.8%
FY May 2024
+0.0%
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
+47.1%
May 2026
+44.8%
Feb 2026
+40.3%
Nov 2025
+40.9%
Aug 2025
+41.3%
May 2025
+41.8%
Feb 2025
+1.3%
Nov 2024
+0.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.2%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on assets PAYX
FY May 2026
+10.8%
FY May 2025
+12.3%
FY May 2024
+0.0%
FY May 2023
n/a
FY May 2022
n/a
Aug 2026
+11.2%
May 2026
+10.8%
Feb 2026
+11.4%
Nov 2025
+11.8%
Aug 2025
+11.9%
May 2025
+12.3%
Feb 2025
+0.4%
Nov 2024
+0.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+25.5%
operating income after a 24.1% effective tax rate, over long-term 2026-08-31 plus current 2026-05-31 plus average of 2025-08-31 and 2026-08-31 minus cash
Return on invested capital PAYX
FY May 2026
+26.8%
FY May 2025
+22.8%
FY May 2024
+53.4%
FY May 2023
+46.8%
FY May 2022
+44.7%
Aug 2026
+25.5%
May 2026
+26.8%
Feb 2026
+24.2%
Nov 2025
+22.7%
Aug 2025
+21.7%
May 2025
+22.8%
Feb 2025
+55.3%
Nov 2024
+51.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+27.4%
operating income (EBIT proxy) over average of 2025-08-31 and 2026-08-31 minus current liabilities
Return on capital employed PAYX
FY May 2026
+26.5%
FY May 2025
+30.1%
FY May 2024
+44.3%
FY May 2023
+44.6%
FY May 2022
+42.5%
Aug 2026
+27.4%
May 2026
+26.5%
Feb 2026
+31.0%
Nov 2025
+30.4%
Aug 2025
+30.0%
May 2025
+30.1%
Feb 2025
+43.2%
Nov 2024
+44.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.91x
close 2026-10-26 over four quarters of diluted EPS, 2025-09-01 to 2026-08-31
P/E, trailing PAYX
FY May 2026
19.79x
FY May 2025
34.55x
FY May 2024
25.73x
FY May 2023
24.40x
FY May 2022
32.25x
Aug 2026
25.22x
May 2026
19.79x
Feb 2026
20.63x
Nov 2025
25.33x
Aug 2025
31.34x
May 2025
34.55x
Feb 2025
31.60x
Nov 2024
30.79x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$45.1B
market value at close 2026-10-26 on 2026-08-31 shares, plus long-term 2026-08-31 plus current 2026-05-31, minus cash 2026-08-31
Enterprise value PAYX
FY May 2026
$38.2B
FY May 2025
$60.2B
FY May 2024
$42.6B
FY May 2023
$37.4B
FY May 2022
$45.1B
Aug 2026
$49.3B
May 2026
$38.2B
Feb 2026
$36.8B
Nov 2025
$43.6B
Aug 2025
$54.3B
May 2025
$60.2B
Feb 2025
$53.9B
Nov 2024
$52.3B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield PAYX
FY May 2026
+6.7%
FY May 2025
+3.0%
FY May 2024
+4.0%
FY May 2023
+4.1%
FY May 2022
+3.3%
Aug 2026
+4.4%
May 2026
+6.7%
Feb 2026
+6.2%
Nov 2025
+5.0%
Aug 2025
+3.7%
May 2025
+3.0%
Feb 2025
+2.9%
Nov 2024
+3.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.70x
P/E over trailing EPS growth of 13%: four quarters to 2026-08-31 against the four to 2025-08-31
PEG, trailing PAYX
FY May 2026
2.74x
FY May 2025
n/a
FY May 2024
2.99x
FY May 2023
2.04x
FY May 2022
1.21x
Aug 2026
1.87x
May 2026
2.74x
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
6.91x
Nov 2024
5.54x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PAYX ranks highest on profitability (86th percentile) and growth (63rd), and lowest on insider conviction (12th), among Services peers.
Profitability
86
Inputs
Return on equity+47.1% · 94 pct, sector of 207
Return on assets+11.2% · 85 pct, sector of 269
Return on invested capital+25.5% · 75 pct, sector of 81
Return on capital employed+27.4% · 92 pct, sector of 203
Financial health
46
Inputs
Debt to equity1.23x · 21 pct, sector of 228
Cash flow to debt0.49x · 70 pct, sector of 199
Growth
63
Inputs
Revenue growth, YoY+16.5% · 73 pct, sector of 341
Backlog growth, YoY+0.9% · 54 pct, sector of 77
Insider conviction
12
Inputs
Net Form 4 buying (codes P and S), 180d-$4.6M · 24 pct, sector of 174
Insider buyers, 180d0 · 0 pct, sector of 179
Institutional and government
55
Inputs
Funds adding, latest quarter791 · 98 pct, sector of 243
Congress net buyers, 365d-1 · 11 pct, sector of 37
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$960K · 57 pct, sector of 61
Risk and compliance
32
Inputs
Short interest, % of float+5.9% · 31 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+15.5% · 34 pct, sector of 227
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PAYX filings, in plain words
Are Paychex insiders buying or selling PAYX?
In the 180 days to 2026-10-28, Paychex insiders were net sellers, a net $4.6M across purchases and sales reported on Form 4, by 6 sellers.
Have members of Congress traded PAYX?
Yes. In the year to 2026-10-28, 2 House members disclosed buying PAYX and 3 House members disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-25.
Are there planned insider sales of PAYX?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $93.9M of stock; the latest, by Golisano B Thomas, was filed 2026-10-23.
Read the full summary
In the 180 days to 2026-10-28, Paychex insiders were net sellers of PAYX, a net $4.6M across purchases and sales reported on Form 4 by 6 sellers. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 2 members of Congress disclosed buying PAYX and 3 members disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-25. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $93.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.